Synoda Pharmaceuticals has established two technical platforms, namely, polypeptide drug R&D platform and advanced intermediate R&D platform.



Peptide drug R&D platform: The core members of the company have long been committed to the development of polypeptide drug production processes and quality research.

Core technologies: Long peptide R&D technology, cyclic peptide R&D technology, and polypeptide modification technology.

Advanced intermediate R&D platform: The core members of the company have long been committed to serving enterprises in the biomedical field.

Core technology: ADC/PDC linker development technology, advanced intermediate customization development technology.